Skin cancer: Role of ultraviolet radiation in carcinogenesis

Reviews on Environmental Health

Volumn 29, Issue 3, 2014, Pages 265-273

  Mancebo, Silvia E ^a   Wang, Steven Q ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

carcinogenesis; skin cancer; UV light

Indexed keywords

DNA DAMAGE; HUMAN; NEOPLASMS, RADIATION-INDUCED; PATHOLOGY; SKIN NEOPLASMS; ULTRAVIOLET RADIATION;

DNA DAMAGE; HUMANS; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84908094995     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh-2014-0041     Document Type: Article

References (87)

1. McKenzie RL, Aucamp PJ, Bais AF, Bjorn LO, Ilyas M, et al. Ozone depletion and climate change: impacts on UV radiation. Photochem Photobiol Sci 2011; 10: 182-98.
2. Andrady AL, Aucamp PJ, Austin AT, Bais AF, Ballare CL, et al. Environmental effects of ozone depletion and its interactions with climate change: progress report, 2011. Photochem Photobiol Sci 2012; 11: 13-27.
3. International Agency for Research on Cancer. Solar and ultraviolet radiation. Lyon: International Agency for Research on Cancer, 1992.
4. Moyal DFA. Acute and chronic effects of UV on skin. In: W. R. Rigel DS, Lim HW, Dover JS editor. Photoaging. New York: Marcel Dekker, Inc., 2004: 15-32.
5. Sayre RM, Dowdy JC, Lott DL, Marlowe E. Commentary on 'UVBSPF': the SPF labels of sunscreen products convey more than just UVB protection. Photodermatol Photoimmunol Photomed 2008; 24: 218-20.
6. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395-401.
7. Diffey BL. What is light? Photodermatol Photoimmunol Photomed 2002; 18: 68-74.
8. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, et al. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010; 19: 1557-68.
9. Whitmore SE, Morison WL, Potten CS, Chadwick C. Tanning salon exposure and molecular alterations. J Am Acad Dermatol 2001; 44: 775-80.
10. Swerdlow AJ, Weinstock MA. Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 1998; 38: 89-98.
11. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002; 94: 224-6.
12. Schulman JM, Fisher DE. Indoor ultraviolet tanning and skin cancer: health risks and opportunities. Curr Opin Oncol 2009; 21: 144-9.
13. Kwon HT, Mayer JA, Walker KK, Yu H, Lewis EC, et al. Promotion of frequent tanning sessions by indoor tanning facilities: two studies. J Am Acad Dermatol 2002; 46: 700-5.
14. Dellavalle RP, Parker ER, Cersonsky N, Hester EJ, Hemme B, et al. Youth access laws: in the dark at the tanning parlor? Arch Dermatol 2003; 139: 443-8.
15. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005; 14: 562-6.
16. Spencer JM, Amonette R. Tanning beds and skin cancer: artificial sun + old sol = real risk. Clin Dermatol 1998; 16: 487-501.
17. Diffey BL. Cosmetic tanning and human skin cancer. Skin cancer: mechanisms and human relevance. Boca Raton, Florida: CRC Press, Inc., 1995: 31-8.
18. Bizzozero J. Winning moves for tanning and equipment: a comprehensive report on the state of the industry. Looking Fit 2002; 17: 38-48.
19. Administration UFaD. FDA to require warnings on sunlamp products. Last updated: May 29, 2014 Accessed on: August 13, 2014. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm399222.htm2014.
20. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol 1999; 135: 519-24.
21. Yones SS, Palmer RA, Garibaldinos TT, Hawk JL. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol 2006; 142: 836-42.
22. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
23. Goeckerman W. The treatment of psoriasis. Northwest Med 1925; 24: 229-31.
24. Roelandts R. The history of phototherapy: something new under the sun? J Am Acad Dermatol 2002; 46: 926-30.
25. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974; 291: 1207-11.
26. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-62.
27. Green C, Ferguson J, Lakshmipathi T, Johnson B. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-6.
28. Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 2005; 52: 660-70.
29. Laube S, George SA. Adverse effects with PUVA and UVB phototherapy. J Dermatolog Treat 2001; 12: 101-5.
30. Archier E, Devaux S, Castela E, Gallini A, Aubin F, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26: 22-31.
31. Velders GJ, Andersen SO, Daniel JS, Fahey DW, McFarland M. The importance of the Montreal Protocol in protecting climate. Proc Natl Acad Sci 2007; 104: 4814-9.
32. Jansen R, Wang SQ, Burnett M, Osterwalder U, Lim HW. Photoprotection: part I. Photoprotection by naturally occurring, physical, and systemic agents. J Am Acad Dermatol 2013; 69: 853. e1-12; quiz 65-6.
33. US Environmental Protection Agency. How is the UV index calculated? Available at: http://www.epa.gov/sunwise/uvicalc.html, Accessed on 15 May 2014. Last updated: April 23, 2012.
34. Seckmeyer G, Erb R, Albold A. Transmittance of a cloud is wavelength-dependent in the UV-range. Geophys Res Lett 1996; 23: 2753-5.
35. Schwander H, Koepke P, Kaifel A, Seckmeyer G. Modification of spectral UV irradiance by clouds. J Geophys Res: Atmos 2002; 107: AAC 7-1-AAC 7-12.
36. Kylling A, Albold A, Seckmeyer G. Transmittance of a cloud is wavelength-dependent in the UV-range: physical interpretation. Geophys Res Lett 1997; 24: 397-400.
37. Diffey B, Diffey J. Sun protection with trees. Br J Dermatol 2002; 147: 397-8.
38. McKenzie R, Weinreis C, Johnston P, Liley B, Shiona H, et al. Effects of urban pollution on UV spectral irradiances. Atmos Chem Phys 2008; 2: 7149-88.
39. An JL, Wang YS, Li X, Sun Y, Shen SH. Relationship between surface UV radiation and air pollution in Beijing. Huan Jing Ke Xue 2008; 29: 1053-8.
40. Rigel DS, Rigel EG, Rigel AC. Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 1999; 40: 114-6.
41. Khavrus V, Shelevytsky I. Geometry and the physics of seasons. Phys Educ 2012; 47: 680.
42. Kullavanijaya P, Lim HW. Photoprotection. J Am Acad Dermatol 2005; 52: 937-58; quiz 59-62.
43. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicology and applied pharmacology 2004; 195: 298-308.
44. Hönigsmann H. Erythema and pigmentation. Photodermatol Photoimmunol Photomed 2002; 18: 75-81.
45. Gilchrest BA, Stoff JS, Soter NA. Chronologic aging alters the response to ultraviolet-induced inflammation in human skin. J Invest Dermatol 1982; 79: 11-5.
46. Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997; 13: 410-4.
47. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA 1997; 94: 11-4.
48. Young AR, Potten CS, Nikaido O, Parsons PG, Boenders J, et al. Human melanocytes and keratinocytes exposed to UVB or UVA in vivo show comparable levels of thymine dimers. J Invest Dermatol 1998; 111: 936-40.
49. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol 2001; 79: 547-68.
50. Deliconstantinos G, Villiotou V, Stravrides JC. Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br J Pharmacol 1995; 114: 1257-65.
51. Abeyama K, Eng W, Jester JV, Vink AA, Edelbaum D, et al. A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest 2000; 105: 1751-9.
52. Lim HW, Honigsmann H, Hawk J. Photodermatology. New York, NY, USA: CRC Press; 2013.
53. Fitzpatrick T. Ultraviolet-induced pigmentary changes: benefits and hazards. Current problems in dermatology 1986; 15: 25.
54. Epstein JH, Fukuyama K, Fye K. Effects of ultraviolet radiation on the mitotic cycle and DNA, RNA and protein synthesis in mammalian epidermis in vivo. Photochem Photobiol 1970; 12: 57-65.
55. Haratake A, Uchida Y, Mimura K, Elias PM, Holleran WM. Intrinsically aged epidermis displays diminished UVB-induced alterations in barrier function associated with decreased proliferation. J Invest Dermatol 1997; 108: 319-23.
56. Ananthaswamy HN, Pierceall WE. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem Photobiol 1990; 52: 1119-36.
57. Black H, DeGruijl F, Forbes P, Cleaver J, Ananthaswamy H, et al. Photocarcinogenesis: an overview. J Photochem Photobiol B: Biol 1997; 40: 29-47.
58. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-8.
59. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, et al. UVinduced skin damage. Toxicology 2003; 189: 21-39.
60. Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005; 571: 3-17.
61. Zhang X, Rosenstein BS, Wang Y, Lebwohl M, Mitchell DM, et al. Induction of 8-oxo-7, 8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells. Photochem Photobiol 1997; 65: 119-24.
62. Rittié L, Fisher GJ. UV-light-induced signal cascades and skin aging. Ageing Res Rev 2002; 1: 705-20.
63. Chen L, Hu JY, Wang SQ. The role of antioxidants in photoprotection: a critical review. J Am Acad Dermatol 2012; 67: 1013-24.
64. Runger TM, Kappes UP. Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 2008; 24: 2-10.
65. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 453-6.
66. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-6.
67. Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996; 88: 1442-55.
68. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res- Fund Mol M 2005; 571: 91-106.
69. Shen Y, White E. p53-dependent apoptosis pathways. Adv Cancer Res 2001; 82: 55-84.
70. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-9.
71. Taguchi K, Fukunaga A, Ogura K, Nishigori C. The role of epidermal Langerhans cells in NB-UVB-induced immunosuppression. Kobe J Med Sci 2013; 59: E1-9.
72. Calzavara-Pinton P, Sala R, Arisi MC, Bussoletti C, Celleno L. Photobiology, photodermatology and sunscreens: a comprehensive overview. Part 1: damage from acute and chronic solar exposure. G Ital Dermatol Venereol 2013; 148: 89-106.
73. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005; 571: 185-205.
74. Kuhn A, Beissert S, Krammer PH. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 2009; 301: 71-81.
75. Mulliken JS, Russak JE, Rigel DS. The effect of sunscreen on melanoma risk. Dermatol Clin 2012; 30: 369-76.
76. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, et al. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 2004; 101: 4954-9.
77. Taguchi M, Watanabe S, Yashima K, Murakami Y, Sekiya T, et al. Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin. J Invest Dermatol 1994; 103: 500-3.
78. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-6.
79. Rady P, Scinicariello F, Wagner RF, Tyring SK. p53 mutations in basal cell carcinomas. Cancer research 1992; 52: 3804-6.
80. Toftgard R. Hedgehog signalling in cancer. Cell Mol Life Sci CMLS 2000; 57: 1720-31.
81. Zhang H. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Path 2001; 158: 381-5.
82. Reifenberger J, Wolter M, Knobbe C, Köhler B, Schönicke A, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005; 152: 43-51.
83. van der Schroeff JG, Evers LM, Boot AJ, Bos JL. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol 1990; 4: 423-5.
84. Green A, Williams G, Neale R, Hart V, Leslie D, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354: 723-9.
85. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15: 2546-8.
86. Dennis LK, Vanbeek MJ, Beane Freeman LE, Smith BJ, Dawson DV, et al. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol 2008; 18: 614-27.
87. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow- up. J Clin Oncol 2011; 29: 257-63.